CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Long-acting Opioids for Chronic Non-cancer Pain: A Review of the Clinical Efficacy and Safety

Last updated: August 27, 2015
Project Number: RC0698-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary with Critical Appraisal
Result type: Report


  1. What is the comparative efficacy and safety of long-acting opioids in adults with chronic non-cancer pain?

Key Message

One systematic review of long-term (>3 months) treatment and one extension study of an earlier randomized controlled trial comparing two opioids were identified. There is insufficient evidence assessing long-acting opioids, and insufficient evidence to discriminate between the four long-acting opioids in terms of efficacy and safety.